ARS Pharmaceuticals Inc (SPRY) stock soared 5.55% in Wednesday's intraday trading, following bullish analyst sentiment on the healthcare company.

According to analyst reports, there is growing optimism surrounding ARS Pharmaceuticals and its peers in the healthcare sector. Analysts have issued favorable recommendations on SPRY, citing the company's strong prospects and growth potential.

The positive analyst coverage has fueled investor confidence in ARS Pharmaceuticals, driving the stock's significant intraday gain of 5.55%. As the healthcare industry continues to garner attention, companies like SPRY with promising outlooks are likely to see increased investor interest and potential upside.